|
業務類別
|
-- |
|
業務概覽
|
Lee's Pharmaceutical Holdings Ltd is a research-driven and market-oriented biopharmaceutical company. Along with its subsidiaries, it develops, manufactures, sells, and markets pharmaceutical products. It focuses on cardiovascular, women'shealth, pediatrics, rare diseases, oncology, dermatology, and obstetrics. The company's reportable segments are; Proprietary and generic products which generates key revenue, and Licensed-in products. The Proprietary Products portfolio includes Livaracine, Yallaferon, Slounase, and Nadroparin Calcium Injection. Its Licensed-in Products include Centraxal Plus, Dicoflor, Ferplex, and Natulan among others. Geographically, the company generates a majority of its revenue from thePeople's Republic of China. |
| 公司地址
| Hong Kong Science Park, 1st Floor, Building 20E, Phase 3, Shatin, Hong Kong, HKG |
| 電話號碼
| +852 23141282 |
| 傳真號碼
| +852 23141708 |
| 公司網頁
| https://www.leespharm.com |
| 員工數量
| 1022 |
| Dr. Xiaoyi Li, PhD |
Director and Chief Executive Officer |
-- |
21/04/2022 |
| Ms. Wanee Leelalertsuphakun |
Director, Managing Director and Chief Marketing and Sales Officer |
-- |
21/04/2022 |
|
|
| Dr. Xiaoyi Li, PhD |
Director and Chief Executive Officer |
21/04/2022 |
| Dr. Yau Ching Bob Chan, B.B.A.,M.B.A.,PhD |
Independent Director |
21/04/2022 |
| Ms. Wanee Leelalertsuphakun |
Director, Managing Director and Chief Marketing and Sales Officer |
21/04/2022 |
| Dr. Wah Keung Karl Tsim, B.Sc. ,M.Phil,PhD |
Independent Director |
21/04/2022 |
| Ms. Siu Fong Lee |
Chairman of the Board |
21/04/2022 |
| Mr. Yat Cheong Lam, B.B.A.,F.C.C.A. |
Independent Director |
21/04/2022 |
| Mr. James C. Gale |
Director |
21/04/2022 |
|
|
|
|
